Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $626.71 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $298.07 | 20 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $149.90 | 1 | $0 (2021) |
| Eisai Inc. | $97.62 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $33.94 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $29.69 | 1 | $0 (2023) |
| Merz Pharmaceuticals, LLC | $17.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.94 | 6 | AstraZeneca Pharmaceuticals LP ($92.45) |
| 2023 | $63.63 | 2 | Actelion Pharmaceuticals US, Inc. ($33.94) |
| 2021 | $300.97 | 6 | BOSTON SCIENTIFIC CORPORATION ($149.90) |
| 2020 | $28.91 | 2 | AstraZeneca Pharmaceuticals LP ($28.91) |
| 2019 | $110.91 | 8 | AstraZeneca Pharmaceuticals LP ($110.91) |
| 2018 | $12.35 | 1 | AstraZeneca Pharmaceuticals LP ($12.35) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Respiratory | ||||||
| 05/17/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Musculoskeletal | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Respiratory | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Respiratory | ||||||
| 07/25/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: Cardiology | ||||||
| 12/20/2021 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $97.62 | General |
| 12/14/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 10/12/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 08/19/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Respiratory | ||||||
| 07/14/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Respiratory | ||||||
| 01/12/2021 | BOSTON SCIENTIFIC CORPORATION | SOLYX (Device) | Food and Beverage | In-kind items and services | $149.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/21/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 04/23/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Respiratory | ||||||
| 10/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
| 09/10/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Respiratory | ||||||
| 08/16/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 08/02/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Respiratory | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 05/30/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Respiratory | ||||||
| 02/12/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Respiratory | ||||||
| 01/09/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Respiratory | ||||||
| 11/20/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 180 | 310 | $105,469 | $31,509 |
| 2022 | 4 | 250 | 490 | $191,889 | $60,784 |
| 2021 | 1 | 71 | 107 | $78,597 | $19,313 |
| 2020 | 2 | 88 | 92 | $63,154 | $14,652 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 88 | $59,356 | $13,684 | 23.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 85 | $18,223 | $7,656 | 42.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 95 | $15,279 | $5,627 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $9,791 | $3,260 | 33.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $2,820 | $1,283 | 45.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 119 | 289 | $155,521 | $46,448 | 29.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 130 | $25,518 | $9,885 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 44 | $5,774 | $2,347 | 40.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 27 | 27 | $5,076 | $2,104 | 41.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 71 | 107 | $78,597 | $19,313 | 24.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 72 | 76 | $57,202 | $13,531 | 23.7% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 16 | 16 | $5,952 | $1,120 | 18.8% |
About Dr. Carlos Silva, MD
Dr. Carlos Silva, MD is a Critical Care Medicine healthcare provider based in Bloomington, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659675296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Silva, MD has received a total of $626.71 in payments from pharmaceutical and medical device companies, with $109.94 received in 2024. These payments were reported across 25 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($626.71).
As a Medicare-enrolled provider, Silva has provided services to 589 Medicare beneficiaries, totaling 999 services with total Medicare billing of $126,258. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Critical Care Medicine
- Location Bloomington, IN
- Active Since 12/22/2010
- Last Updated 07/24/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1659675296
Products in Payments
- FASENRA (Drug) $152.17
- SOLYX (Device) $149.90
- FASENRA (Biological) $145.90
- UPTRAVI (Drug) $33.94
- ACTHAR (Biological) $29.69
- Xeomin (Biological) $17.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Bloomington
Dr. Eric Trueblood, M.d, M.D
Critical Care Medicine — Payments: $13,926
Rajeev Varma, Md, MD
Critical Care Medicine — Payments: $7,713
Karen Sayad, Md, MD
Critical Care Medicine — Payments: $6,830
Helen Kirk, M.d, M.D
Critical Care Medicine — Payments: $856.21
Yaser Abu El-Sameed, M.d, M.D
Critical Care Medicine — Payments: $127.14
Vincent Holly, Rn, Aprn, Cns, RN, APRN, CNS
Critical Care Medicine — Payments: $68.55